On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Hims & Hers Health (HIMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

The overall sentiment of these big-money traders is split between 31% bullish and 50%, bearish. Out of all of the special options we uncovered, 3 are puts, for a total amount of $106,898, and 13 are ...

An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...

Getting a strong erection is a complicated physiological process that requires precise coordination of many body systems.

Prescription volume for specialty medications, not price hikes, largely seems to be the main factor in the ongoing huge ...

Chevron has won a major arbitration battle with Exxon Mobil, removing a key obstacle to its planned acquisition of Hess.

Netflix topped Wall Street expectations in the second quarter, boosted by strong subscriber growth, rising ad revenue, and hit content.

The post Enigmas Never Age appeared first on Reason.com.

The Philippines’ IT and Business Process Management (IT-BPM) sector has evolved from a voice-centric call center base into a hub for high-value services. With a strong shift toward finance, healthcare ...

Due to biological differences in metabolism, body composition, and hormones, men generally burn more calories than women.